02/24/2016 10:54 EST | Updated 02/24/2016 11:59 EST

Johnson & Johnson To Pay US$72M In Talcum Powder Cancer Case

ST. LOUIS — A Missouri jury has awarded $72 million to the family of an Alabama woman who died from ovarian cancer, which she said was caused by using Johnson & Johnson's well-known baby powder and other products containing talcum.

The civil suit by Jackie Fox of Birmingham was part of a broader claim in the city of St. Louis Circuit Court involving nearly 60 people. Her son took over as plaintiff following his mother's October 2015 death at 62, more than two years after her diagnosis.

Marvin Salter of Jacksonville, Florida, said his late mother, who was a foster parent, used the iconic talcum powder as a bathroom staple for decades.

"It just became second nature, like brushing your teeth,'' he said. "It's a household name. ''

A Fox attorney said the jury verdict Monday night, which came after nearly five hours of deliberations at the conclusion of a three-week trial, was the first such case among more than 1,000 nationally to result in a jury's monetary award.

johnson and johnson powder

The jury said that Fox was entitled to $10 million in actual damages and $62 million in punitive damages. Attorney James Onder said he "absolutely'' expects Johnson & Johnson — the world's biggest maker of health care products — to appeal the verdict.

The New Jersey-based company previously has been targeted by health and consumer groups over possibly harmful ingredients in items including its iconic Johnson's No More Tears baby shampoo.

In May 2009, a coalition of groups called the Campaign for Safe Cosmetics began pushing Johnson & Johnson to eliminate questionable ingredients from its baby and adult personal care products. After three years of petitions, negative publicity and a boycott threat, the company agreed in 2012 to eliminate the ingredients 1,4-dioxane and formaldehyde, both considered probable human carcinogens, from all products by 2015.

Spokeswoman Carol Goodrich said Tuesday that the New Jersey-based company was considering its next legal move. In a written statement, she said the verdict "goes against decades of sound science proving the safety of talc as a cosmetic ingredient in multiple products,'' citing supportive research by the U.S. Food and Drug Administration and National Cancer Institute.

At trial, Fox's attorneys introduced into evidence a September 1997 internal memo from a Johnson & Johnson medical consultant suggesting that "anybody who denies (the) risks'' between "hygienic'' talc use and ovarian cancer will be publicly perceived in the same light as those who denied a link between smoking cigarettes and cancer: "denying the obvious in the face of all evidence to the contrary.''

"This case clearly was a bellwether, and clearly the jury has seen the evidence and found it compelling."

Talc is naturally occurring, mined from the soil and composed of magnesium, silicon, oxygen, and hydrogen. It's widely used in cosmetics and personal care products, such as talcum powder, to absorb moisture, prevent caking and improve the product's feel.

Nora Freeman Engstrom, a Stanford University law professor not involved in the Missouri case, said it's unlikely the $72 million award will survive, noting that the U.S. Supreme Court, in a recent series of rulings, has maintained that appellate courts clamp down on punitive damages.

"Big jury verdicts do tend to be reined in during the course of the appellate process, and I expect that to be the case here,'' she told The Associated Press.

The verdict Monday "doesn't bode well for Johnson & Johnson'' as it faces at least 1,200 still-pending lawsuits and possibly thousands more, she said.

"This case clearly was a bellwether, and clearly the jury has seen the evidence and found it compelling,'' she said, concluding " the jury was distressed by the company's conduct.''


Associated Press reporters Jim Suhr in Kansas City, Missouri, and business writer Linda A. Johnson in Trenton, New Jersey, contributed to this report.

Also on HuffPost

  • 芽キャベツ、ケール、カリフラワーなど
  • コーヒー
    コーヒーは、脳腫瘍や口腔がん、咽頭がんのリスクを減らす可能性があると言われているが、それは抗酸化物質とポリフェノールに相乗効果によるものだと考えられている。学術誌「Cancer Epidemiology, Biomarkers & Prevention」に掲載された研究では、1日に5杯以上のコーヒーまたは紅茶を飲むと、グリオーマや脳腫瘍の発生リスクが減る可能性があることが明らかになった。

    また別の学術誌「American Journal of Epidemiology」に掲載された研究によれば、1日に4杯以上のコーヒーを飲む人は、飲まないもしくは時々飲む人と比較して口腔がんや咽頭がんのリスクが49%低いことが観察された。
  • ギリシャヨーグルトやカッテージチーズ、スムージー


    カルシウムにどんな抗がん作用があるのか専門家たちも正確にはわかっていないが、1つの可能性としては、細胞分裂が制御不能になるのを防止する可能性が指摘されている (ただし、カルシウムの大量摂取は前立腺がんのリスクを増加させる可能性もあるので、男性は気をつけた方がよさそうだ)。
  • イタリア料理や地中海料理

  • トマト
    医学誌「Journal of the National Cancer Institute」に掲載された研究によると、トマトやトマト製品(ソースやペーストなど)をたくさん摂取すると、肺がんや胃がん、さらに膵臓がん、結腸がん、直腸がん、食道がん、口腔がん、乳がん、頸がんのリスクを押し下げる可能性がある。